Home > Products > CD3 & IL2R
> Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scDiabody-CH3)
Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scDiabody-CH3) (CAT#: SCDBC-093)
Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scDiabody-CH3) is a fusion protein of two scDiabodies connected together by a CH3 region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-CD3/anti-IL2R diabody. The scDiabody with two specificities is fused to each of the CH3 chains to extend half-life. This BsAb can retarget T cells to tumor cells. It is designed for the research of Hodgkin lymphoma; Non-Hodgkin's lymphoma (NHL); Acute lymphocytic leukemia (ALL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (scDiabody-CH3) (SCDBC-093). Click the button below to contact us or submit your feedback about this product.